Style | Citing Format |
---|---|
MLA | Mozafar M, et al.. "Investigating Neurological Manifestations of Sars-Cov-2." Journal of Neuroimmune Pharmacology, vol. 16, no. 4, 2021, pp. 695-698. |
APA | Mozafar M, Mirmotalebisohi SA, Sameni M, Zali H (2021). Investigating Neurological Manifestations of Sars-Cov-2. Journal of Neuroimmune Pharmacology, 16(4), 695-698. |
Chicago | Mozafar M, Mirmotalebisohi SA, Sameni M, Zali H. "Investigating Neurological Manifestations of Sars-Cov-2." Journal of Neuroimmune Pharmacology 16, no. 4 (2021): 695-698. |
Harvard | Mozafar M et al. (2021) 'Investigating Neurological Manifestations of Sars-Cov-2', Journal of Neuroimmune Pharmacology, 16(4), pp. 695-698. |
Vancouver | Mozafar M, Mirmotalebisohi SA, Sameni M, Zali H. Investigating Neurological Manifestations of Sars-Cov-2. Journal of Neuroimmune Pharmacology. 2021;16(4):695-698. |
BibTex | @article{ author = {Mozafar M and Mirmotalebisohi SA and Sameni M and Zali H}, title = {Investigating Neurological Manifestations of Sars-Cov-2}, journal = {Journal of Neuroimmune Pharmacology}, volume = {16}, number = {4}, pages = {695-698}, year = {2021} } |
RIS | TY - JOUR AU - Mozafar M AU - Mirmotalebisohi SA AU - Sameni M AU - Zali H TI - Investigating Neurological Manifestations of Sars-Cov-2 JO - Journal of Neuroimmune Pharmacology VL - 16 IS - 4 SP - 695 EP - 698 PY - 2021 ER - |